Monday December 01 2008 | Biotechnology feed | All feeds
|
|
Monday December 01 2008 | Biotechnology feed | All feeds
|
|
|
Roche Vitamins and UpFront Chromatography sign global licence agreement Roche Vitamins has signed a global licence agreement with UpFront Chromatography, an innovative Danish technology company. Roche Vitamins will use the Expanded Bed Adsorption (EBA) technology developed by UpFront Chromatography for the production of certain ingredients for feed, food, pharmaceutical and cosmetics applications. The financial terms of the agreement were not disclosed.EBA is a highly efficient technique for the extraction of target molecules directly from unclarified crude feedstock. Unlike traditional methods of protein isolation, EBA combines the steps into a single procedure. This technology enables the extraction of compounds that are very diluted and optimises production processes. Allan Lihme, Managing Director of UpFront Chromatography, says, "The agreement underlines the great potential of the EBA technology. Roche Vitamins' leading market position and its history of innovation make it an ideal licence partner for UpFront Chromatography." Manfred Eggersdorfer, Head of Research and Development of Roche Vitamins: "The agreement with Upfront Chromatography gives us access to an innovative extraction technology. It offers potential for applications in many processes we develop." UpFront Chromatography is a Danish biotech company with a strong IPR-based technology platform in the area of solid-phase separation technologies and EBA. The UpFront EBA technology is commercially applied in several industries, e.g. production of enzymes, food and nutraceutical ingredients, and bio-pharmaceuticals. More information about UpFront Chromatography is available on the Internet at www.upfront-dk.com . Roche's Vitamins and Fine Chemicals Division is the world's leading supplier of vitamins and carotenoids to the feed, food, pharmaceutical and cosmetics industries. It has its own research centres, production facilities and worldwide sales and distribution network. In 2002, it employed 7300 people and recorded sales of approx. 3.4 billion Swiss francs. As announced, Roche has sold its Vitamins and Fine Chemicals Division to DSM, pending approval of the merger control authorities. For further company information, visit Roche Vitamins on the Internet at www.roche-vitamins.com . Roche Vitamins Ltd. Vitamins and Fine Chemicals Division Media Office CH-4070 Basel Tel. +41 61 688 8514 Fax +41 61 687 3716 |
|
|
